Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care

Haematologica. 2020 Sep 1;105(9):e474-479. doi: 10.3324/haematol.2019.240762.

Authors

Affiliations

¹ Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. faouzi.djebbari@ouh.nhs.uk.
² Department of Haematology, Larissa University Hospital, Larissa, Greece.
³ Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁴ Department of Pharmacy, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

No abstract available

Publication types

Letter

MeSH terms

Bortezomib
Humans
Morbidity
Multiple Myeloma* / diagnosis
Multiple Myeloma* / epidemiology
Multiple Myeloma* / therapy
Standard of Care
United Kingdom / epidemiology

Substances

Bortezomib